Virtus (VRTS) Q1 2026 Earnings Transcript

Virtus reported AUM of $149 billion at March 31, down from $159 billion, with $8.4 billion of net outflows in the quarter, though sales rose 8% to $5.8 billion and equity sales jumped 26%. Operating income as adjusted fell to $43.8 million from $61.1 million, and adjusted EPS declined to $5.38, pressured by seasonal employment expenses and lower average AUM. Offseting some of the weakness, ETF AUM reached $5.4 billion, Keystone added $2.3 billion of AUM, and the company repurchased $10 million of stock while maintaining leverage at 1.1x EBITDA.

Analysis

VRTS is in a classic transition phase where headline flows still look weak, but the mix is improving underneath. The key second-order signal is that the worst redemptions were concentrated early in the quarter while March/April improved, which matters because asset managers tend to re-rate on flow inflections before AUM and earnings visibly recover. If that improvement persists for even 1-2 more months, the market can start looking through current EBITDA pressure and focus on the higher-fee mix from ETFs, SMAs, and private credit.

The Keystone deal is more than additive AUM; it changes the earnings architecture. Private credit should raise the fee rate and improve revenue durability, but it also increases complexity: deferred consideration, future ownership increases, and integration risk can create a lag between reported AUM growth and realized margin expansion. The balancing act is that management is effectively buying a more resilient alternative revenue stream while funding it with a leverage uptick and lower cash, so the equity story becomes less about net inflows in legacy equity and more about whether alternatives can offset cyclical drawdowns.

Competitively, the biggest winner is likely the distribution channel rather than any single product line: reopened SMidCap, ETF launches, and differentiated private credit all give advisors a broader shelf-set to keep assets within one platform. The loser is the legacy quality/growth franchise if style headwinds persist longer than expected, because the business becomes increasingly reliant on cross-selling and wrapper migration to mask gross redemptions. The market is likely underappreciating how much a few basis points of fee-rate expansion can matter here versus raw AUM changes, but it is also probably underpricing the volatility of institutional flows and model-driven retail accounts.

The contrarian take is that the stock may not need “good flows” to work; it needs less-bad flows plus sustained fee mix improvement. With leverage modest and capital returns continuing, downside looks more like multiple compression risk from another weak quarter than balance-sheet stress. The stock becomes interesting if management can show two consecutive quarters of improving net sales in March/April-style trend, because that would validate that the trough in legacy equity outflows is behind them and the alternatives/ETF growth engine is real.

Key Decisions for Investors

• Initiate a tactical long in VRTS over the next 2-6 weeks ahead of Q2 flow data; use the setup as a re-rating trade on improving monthly flow momentum and Keystone margin lift. Risk/reward is attractive if the market moves from 'flow deterioration' to 'flow normalization,' but cut exposure if April trends do not persist.
• Pair trade: long VRTS / short a higher-beta asset manager with weaker product diversification and no private-markets catalyst. The thesis is that VRTS has a clearer mix-improvement path while still trading like a pure equity-flow story.
• Buy VRTS common only on pullbacks if it holds above levels implied by ~1.1x net debt/EBITDA; the balance sheet is not the problem, so any selloff tied solely to quarterly AUM volatility is likely overstated. Time horizon: 3-6 months.
• Consider selling out-of-the-money calls against a VRTS long if you want to monetize elevated uncertainty around flows and integration, especially after any bounce on better monthly data. This caps upside but improves carry while waiting for fee-rate expansion to show up.
• Watch for a confirmation trade in alternatives-linked peers if VRTS demonstrates Keystones-scale distribution traction; if that happens, rotate into the basket rather than just the name, because the market will likely revalue the whole alternatives/distribution complex.